Chuck Royce (Royce & Associates) add ARS Pharmaceuticals, Inc.
Chuck Royce (Royce & Associates) add $10.0M of disclosed value in ARS Pharmaceuticals, Inc..
Signal
Investor Move
Action
Add
Capital
$10.0M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.